TAYLOR BEN R (Chief Financial Officer) reported 1 transaction at RECURSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 12/17/2025ACC: 0001712276-25-000015
Officer· Chief Financial Officer
Since Feb 2026
-7.06K
Net shares
Net seller
$30.6K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
7.06K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−7.06K
Price / share
$4.33
Trade value
$30.56K
% of position
0.9%
12/15/2025
789.99K→782.93K
Total
Net shares
−7.06K
Net value
-$30.56K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 12/15/2025 | F · Tax Withholding | −7.06K | $4.33 | $30.56K | 0.9% | 789.99K | 782.93K |
| Total | −7.06K | -$30.56K | ||||||
Derivative Transactions0
No derivative transactions reported